Skip to main navigation Skip to search Skip to main content

Ultra-sensitive detection of circulating tumour DNA enriches for patients with greater risk of recurrence in clinically localised prostate cancer

  • Bernard Pope*
  • , Gahee Park
  • , Edmund Lau
  • , Jelena Belic
  • , Radoslaw Lach
  • , Anne George
  • , Patrick McCoy
  • , Anne Nguyen
  • , Corrina Grima
  • , Bethany Campbell
  • , Chol-hee Jung
  • , Emma-Jane Ditter
  • , Hui Zhao
  • , David Wedge
  • , Daniel Brewer
  • , Andy Lynch
  • , Harveer Dev
  • , Vincent Gnanpragasam
  • , Nitzan Rosenfeld
  • , Christopher Hovens
  • Niall Corcoran, Charlie Massie, CR-UK/Prostate Cancer UK, ICGC, The PPCG
*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish
Pages (from-to)407-410
Number of pages4
JournalEuropean Urology
Volume85
Issue number4
Early online date19 Feb 2024
DOIs
Publication statusPublished - 1 Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Male
  • Humans
  • Circulating tumor DNA/genetics
  • Prostatic neoplasms/pathology
  • Prostate-specific antigen
  • Neoplasm recurrence, local/genetics
  • Prostatectomy

Cite this